Download presentation

Presentation is loading. Please wait.

Published byJames Atkinson Modified over 4 years ago

1
Identifying Meaningful Patient Subgroups via Clustering - Sensitivity Graphics Bob Obenchain Commercial Information Sciences Outcomes Research, US Medical Division

2
Rosenbaum PR. Observational Studies, Second Edition. New York: Springer- Verlag. 2002, page 5. In its essence, to adjust for age is to compare smokers and nonsmokers of the same age. …differences … in age-adjusted mortality rates cannot be attributed to differences in age. Adjustments of this sort, for age or other variables, are central to the analysis of observational data.

3
Cochran WG, Cox G. Experimental Designs 1957 BlockingBlocking RandomizationRandomization ReplicationReplication

4
Epidemiology (case-control & cohort) studies Post-stratification and re-weighting in surveys Stratified, dynamic randomization to improve balance on predictors of outcome Full Matching on Propensity Score estimates Econometric Instrumental Variables (LATEs) Marginal Structural Models (InvProbWgt 1/PS) Unsupervised Propensity Scoring: Nested (Treatment within Cluster) ANOVA …with LOA, LTD and Error components Forms of Local Control for Human Studies

5
Local Terminology: Subgroups of Patients Subclasses… Strata… Clusters…

6
Source Degrees-of- Freedom Interpretation Clusters (Subgroups) C = Number of Clusters Local Average Treatment Effects (LATEs) are Cluster Means Treatment within Cluster Number of Informative Clusters C Local Treatment Differences (LTDs) Error Number of Patients 2C Uncertainty Although a NESTED model can be (technically) WRONG, it is sufficiently versatile to almost always be USEFUL as the number of clusters increases. Nested ANOVA

7
In general, subgroups of patients can be considered meaningful only if patients are much more similar within subgroups than between subgroups.

8
Notation for Variables y = observed outcome variable(s) x = observed baseline covariate(s) t = observed treatment assignment (usually non-random) z = unobserved explanatory variable(s)

9
When making head-to-head treatment comparisons, subgroups of patients remain meaningful only if the observed distributions of within subgroup differences in outcome due to treatment also differ among subgroups.

11
Meaningful subgroups can only contain smaller patient subgroups that are not meaningful. Overshooting!!!

12
16 Clusters (each containing both treated and untreated patients) in a two dimensional X-space Different Possible LTD Distributions of Y Outcomes will be Illustrated here in the Bottom Half of the Following Slides...

13
These clusters may NOT be meaningful when the resulting distribution of treatment differences in Y looks quite peaked: Main Effect with Little Noise 16 Clusters (each containing both treated and untreated patients) in a two dimensional X-space

14
However, these clusters are meaningful when the resulting distribution of treatment differences in Y is different from the corresponding distribution using RANDOM subgroups: 16 Clusters (each containing both treated and untreated patients) in a two dimensional X-space

15
Artificial LTD Distributions from Random Subgroupings… Relatively Flat?, Smooth? or Unimodal? Maximum Uncertainty and Bias because least relevant comparisons are included !!! LTD Distributions from Subgroups Relatively Well-Matched in X-space… Shifted Mean? Skewness? Distinct Local Modes? Lower Local Variability? …Meaningful!

16
These clusters may be meaningful when the distribution of treatment differences in Y looks something like this: 16 Clusters (each containing both treated and untreated patients) in a two dimensional X-space

17
These 7 clusters are meaningful when the distribution of treatment differences reveals a local mode attributable to adjacent clusters: 16 Clusters (each containing both treated and untreated patients) in a two dimensional X-space

18
Clusters could fail to remain meaningful if the local mode in the distribution of treatment differences corresponds to outcomes from widely dispersed clusters: 16 Clusters (each containing both treated and untreated patients) in a two dimensional X-space

19
Subgroup-based approaches used in Observational Human Studies face reality: 1.(Non-parametric) Nested ANOVA models (treatment within subgroup) are robust. 2.Sometimes, its just not possible to make clearly fair comparisons! Traditional Covariate Adjustment methods used in Randomized Clinical Trials (i.e. Least Square Means) make very strong assumptions: 1.Their (complex?) parametric models are correct. 2.Factors should compete for (causal) credit.

20
Global / Marginal Inference… Difference of Overall Averages …one average for each treatment group or a simple contrast (single degree-of-freedom) Local / Conditional Inference… Distribution of Local Differences …one treatment difference within each informative subgroup of similar patients What is a Treatment Effect?

21
Mortality Rates: Simpsons Paradox MildSevere W-Class1% 6% Local3% 9% Difference: 2% 3% Total 4.4% 3.8% Mild Severe Total W-Class3/32741/678 44/1005 Local8/258 3/33 11/291 Total 11/58544/711 Disease severity is a confounder here in the sense that it is associated with both outcome (mortality) and treatment choice (hospital.) +0.6%

22
i.e. not Generalized Linear Models and their Nonlinear extensions. The statistical methodology engine ideal for making fair treatment comparisons is: Cluster Analysis (Unsupervised Learning) plus Nested ANOVA

23
Is there statistical theory suggesting use of clustering to identify treatment effects?

24
Fundamental PS Theorem Joint distribution of x and t given p: Pr( x, t | p ) = Pr( x | p ) Pr( t | x, p ) = Pr( x | p ) Pr( t | x ) = Pr( x | p ) times p or (1 p ) = Pr( x | p ) Pr( t | p )...i.e x and t are conditionally independent given the propensity for new, p = Pr( t = 1 | x ).

25
Conditioning (patient matching) on estimated Propensity Scores implies both… Balance: local X-covariate distributions must be the same for both treatments and Imbalance: Unequal local treatment fractions unless Pr( t | p ) = p = 1 p = 0.5

26
Pr( x, t | p ) = Pr( x | p ) Pr( t | p ) The unknown true propensity score (in non-randomized studies) is the most coarse possible balancing score. The known X-vector itself is the most detailed balancing score… Pr( x, t ) = Pr( x ) Pr( t | x )

27
The known X-vector itself is the most detailed balancing score… Pr( x, t ) = Pr( x ) Pr( t | x ) Pr( x, t | p ) = Pr( x | p ) Pr( t | p ) The unknown true propensity score (in non- randomized studies) is the most coarse possible balancing score.

28
Conditioning upon Cluster Membership is intuitively somewhere between the two PS extremes in the limit as individual clusters become numerous, small and compact… The known X-vector itself is the most detailed balancing score… Pr( x, t ) = Pr( x ) Pr( t | x ) Pr( x, t | C ) Pr( x | C ) Pr( t | x, C ) constant Pr( t | C ) Pr( x, t | p ) = Pr( x | p ) Pr( t | p ) The unknown true propensity score (in non- randomized studies) is the most coarse possible balancing score.

29
Start by Clustering Patients in X-Space Divisive Coefficient = 0.98 3 clusters 21 clusters

30
In Observational Human Studies, fraction treated (imbalance) varies even more from subgroup to subgroup due to: 3. Treatment Selection Biases In Randomized Experiments, fraction treated (imbalance) will vary from subgroup to subgroup due to: 1.Bad Luck (Murphys Law) 2.Small Subgroups

31
Source Degrees-of- Freedom Interpretation Clusters (Subgroups) C = Number of Clusters Local Average Treatment Effects (LATEs) are Cluster Means Treatment within Cluster Number of Informative Clusters C Local Treatment Differences (LTDs) Error Number of Patients 2C Uncertainty Although a NESTED model can be (technically) WRONG, it is sufficiently versatile to almost always be USEFUL as the number of clusters increases. Nested ANOVA

32
Nested ANOVA Treatment Difference within i th Cluster: Local Treatment Imbalance!

33
Local Control: A Subgroup / Sensitivity Graphics approach to Robustness Replace covariate adjustment based upon a global model with inference based upon local clustering (sub- grouping) of patients in X-covariate space. Explore sensitivity by increasing the number of clusters, intentionally over-shooting, then recombining. Also vary distance metric and clustering method while employing computationally intensive algorithms and interactive graphical displays.

34
Urgent need for Up Front Sensitivity Analyses Common Threads: Many possible answers !!! No single approach nor set of assumptions is clearly most appropriate.

35
Survey of 1314 Whickham Women y = 20 year mortality (yes or no) in 1995 follow-up study of a survey made in 1972-1974 x = age decade (20, 30, 40, 50, 60, 70 or 80) at the time of the initial survey t = smoker or non-smoker at the time of the initial survey Appleton DR, French JM, Vanderpump MPJ. Ignoring a Covariate: An Example of Simpsons Paradox Amer. Statist. 1996; 50: 340-341.

36
20 Year Mortality Rate Difference Overall Mean and +/-Two Sigma Limits for the Distribution of LTD Differences: Mortality Rate of Smokers minus that of Nonsmokers. Number of Clusters

37
Simpsons Paradox At Work: Percentage of Smokers by Age Decade …and 20 Year Mortality Percentages for Smokers and Non-Smokers

38
LTD Distribution of Heteroskedastic Estimates… 49 Informative Clusters for 20 Year Mortality of 1314 Wickham Women: Smokers minus Nonsmokers CDF KEY QUESTIONS: Is this distribution mostly just noise around some central value? How many local modes might this distribution really have? Do the Xs predict the most likely LTD for some (or all) patients?

39
2 3 1 | 1 2 |/ Mixture Joint Density:

40
Continuing evolution in methodologies for and attitudes about analyses of non- randomized human studies Postpone decisions whenever available data are insufficient to provide high confidence Statistical methods CAN work better-and- better in the dense data limit Future Needs

41
Hansen BB. Full matching in an observational study of coaching for the SAT. JASA 2004; 99: 609-618. Fraley C, Raftery AE. Model based clustering, discriminant analysis and density estimation. JASA 2002; 97: 611-631. Imbens GW, Angrist JD. Identification and Estimation of Local Average Treatment Effects. Econometrica 1994; 62: 467- 475. McClellan M, McNeil BJ, Newhouse JP. Does More Intensive Treatment of Myocardial Infarction in the Elderly Reduce Mortality?: Analysis Using Instrumental Variables. JAMA 1994; 272: 859-866. References

42
McEntegart D. The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview. Drug Information Journal 2003; 37: 293-308. Obenchain RL. Unsupervised Propensity Scoring: NN and IV Plots. 2004 Proceedings of the ASA. Obenchain RL. Unsupervised and Supervised Propensity Scoring in R: the USPS package March 2005. http://www.math.iupui.edu/~indyasa/download.htm. Rosenbaum PR, Rubin RB. The Central Role of the Propensity Score in Observational Studies for Causal Effects. Biometrika 1983; 70: 41-55. Rosenbaum PR. Observational Studies, Second Edition. 2002. New York: Springer-Verlag. References …concluded

43
Backup

44
Current Guideline Initiatives… Randomized Clinical Trials –CONSORT: www.consort-statement.orgwww.consort-statement.org Observational & Non-randomized Studies –STROBE: www.strobe-statement.orgwww.strobe-statement.org –TREND: www.trend-statement.orgwww.trend-statement.org

45
The Propensity Score of a Patient with Baseline Characteristic Vector x : PS = Pr( t | x ) is a vector of conditional probabilities that sum to 1. The length of the PS vector is the total (finite) number of different treatments.

46
Propensity Scores for only 2 Treatments: t = 1 (new) or 0 (standard) p = Propensity for New Treatment = Pr( t = 1 | X ) = E( t | X ) = a scalar valued function of X only X = vector of baseline covariate values for patient PS = (p, 1 p)

47
0 Y-outcome-difference

49 0

50 0

Similar presentations

OK

Observational Studies Based on Rosenbaum (2002) David Madigan Rosenbaum, P.R. (2002). Observational Studies (2 nd edition). Springer.

Observational Studies Based on Rosenbaum (2002) David Madigan Rosenbaum, P.R. (2002). Observational Studies (2 nd edition). Springer.

© 2018 SlidePlayer.com Inc.

All rights reserved.

To make this website work, we log user data and share it with processors. To use this website, you must agree to our Privacy Policy, including cookie policy.

Ads by Google